CP-751,871

dalotuzumab · Pfizer

Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for CP-751,871, covering 2013-02-25 to 2016-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma [Phase 2]